Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
about
Psychostimulants and cognition: a continuum of behavioral and cognitive activationPsychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophyTreatment of narcolepsy and other hypersomnias of central originPractice parameters for the treatment of narcolepsy and other hypersomnias of central originFatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe diseaseA review of the use of modafinil for attention-deficit hyperactivity disorder.Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliabilityDoes modafinil enhance activity of patients with myotonic dystrophy?: a double-blind placebo-controlled crossover study.Modafinil: new indications for wake promotion.Respiratory involvement in inherited primary muscle conditions.Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.Assessment and management of fatigue in neuromuscular disease.Daytime sleepiness and myotonic dystrophy.Sleep-Wake Cycle and Daytime Sleepiness in the Myotonic DystrophiesModafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study.Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.Sleepiness and Sleep-related Breathing Disorders in Myotonic Dystrophy and Responses to Treatment: A Prospective Cohort Study.Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1.
P2860
Q22242285-34EE04A9-3DEE-438F-9045-2D1F794BD3EDQ24245250-48EF4D50-2B0E-4722-8742-896E0B657AF5Q24648883-78E061E7-1708-45B2-94FD-6F43E1D5ED88Q24648903-F95B8CDF-DE62-4CF0-8B35-A070F41FA5E9Q33666033-A1D6A6BF-25B3-4CC3-85B0-B9D753DBA064Q33995154-C8A41956-FF1F-413C-AF82-96EFAAFA8072Q35041851-3E7802DC-BE0B-4D2A-802F-EACF95D1A0C1Q35484170-FE16D8F9-7122-4E96-B10D-335B05A38C02Q35884345-FDE9BDF5-E01C-412F-8224-2BA5F1EA4276Q36040715-B17E3390-FE22-4020-B07F-43DFE5FD9821Q36596271-F6534F1E-9638-4676-A0CC-90F1E33B0BA8Q36632760-0A0FF0AA-5808-4F57-9343-14676E64232DQ37700000-18F9D509-3751-4CE7-95C6-7DA2793F1447Q38083615-BA88D633-5F32-4E38-AEDE-2BF1A197CC1AQ38575770-34131CE4-458D-402C-81AF-916C301915AAQ45286756-68BC1FA9-DB55-4716-B94E-25C7A8D9ED4CQ46792317-5B0A970C-4CA9-4981-A0BE-747D0361E2EFQ47788130-95A08596-0670-4A59-B059-67E2FD2BDA15Q50210167-B4D1E66E-D3D9-4A18-AB69-3FF2C3A5E6C4
P2860
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
@en
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
@nl
type
label
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
@en
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
@nl
prefLabel
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
@en
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
@nl
P2093
P1476
Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy.
@en
P2093
Hilton-Jones D
P304
P356
10.1016/S0960-8966(03)00030-0
P577
2003-06-01T00:00:00Z